Seattle Genetics, Inc. (NASDAQ: SGEN) today announced that its collaborator, Millennium: The Takeda Oncology Company, a wholly owned subsidiary of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE